Iopamidol Injectable Solution

Iopamidol Injectable Solution

Form: Injectable Solution

Strength: 37%, 61%, 76%, and 78%

Reference Brands: Isovue(US), Iopamiro(EU)

Category: Contrast Agent

Iopamidol injectable solution, marketed as Isovue in the US and Iopamiro in the EU, is approved for use as a contrast agent in X-ray and CT imaging. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability, facilitating high-quality diagnostic imaging in healthcare systems globally.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Sulfur Hexafluoride Microbubbles injection

Strength: 60.7mg

Form: injection

Reference Brands: SonoVue(EU)

View Details Get Enquiry
Barium Sulfate Suspension

Strength: 30% w/v , 40% w/v

Form: Powder for oral suspension

Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)

View Details Get Enquiry
Gadoxetate Injectable Solution

Strength: 0.25 mmol/mL

Form: Injectable Solution

Reference Brands: Eovist(US)

View Details Get Enquiry
Gadofosveset Injectable solution

Strength: 0.03 mmol/kg

Form: Injectable Solution

Reference Brands: Ablivar(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.